|
⚲
|
| Keyboard |
| Hardie Robert D
✚
|
|
|---|---|
| CIK # | 0001804350 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001804350] | |
| 4 | [0001804350] | |
| SC 13G | [0001804350] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Hardie Robert D | Ziopharm Oncology Inc | [2020-02-24] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Acumen Pharmaceuticals Inc | |
| Hardie Robert D | |
| PLx Pharma Winddown Corp | |
| Hardie Molly G | |
| Level One Partners LLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Acumen Pharmaceuticals Inc ABOS
Common Stock
|
2021-07-06 | Conversion | 1,124,830 | ||
|
Acumen Pharmaceuticals Inc ABOS
Common Stock
|
2021-07-06 | Buy | 750,000 | $16.00 | 12,000,000 |
|
Acumen Pharmaceuticals Inc ABOS
Common Stock
|
2021-07-06 | Conversion | 2,076,326 | ||
|
Acumen Pharmaceuticals Inc ABOS
Series B Preferred Stock · derivative
|
2021-07-06 | Conversion | 2,076,326 | $0.00 | |
|
Acumen Pharmaceuticals Inc ABOS
Series A-1 Preferred Stock · derivative
|
2021-07-06 | Conversion | 1,124,830 | $0.00 | |
|
Acumen Pharmaceuticals Inc ABOS
Common Stock
|
2021-07-06 | Buy | 312,500 | $16.00 | 5,000,000 |
|
Acumen Pharmaceuticals Inc ABOS
Common Stock
|
2021-07-06 | Conversion | 2,950,484 | ||
|
Acumen Pharmaceuticals Inc ABOS
Common Stock
|
2021-07-06 | Conversion | 657,985 | ||
|
Acumen Pharmaceuticals Inc ABOS
Series B Preferred Stock · derivative
|
2021-07-06 | Conversion | 1,315,969 | $0.00 | |
|
Acumen Pharmaceuticals Inc ABOS
Series B Preferred Stock · derivative
|
2021-07-06 | Conversion | 657,985 | $0.00 | |
|
Acumen Pharmaceuticals Inc ABOS
Series A-1 Preferred Stock · derivative
|
2021-07-06 | Conversion | 1,634,515 | $0.00 |